LETTERS FOR ISSUE ON

Similar documents
LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

TODAY LETTER DATED

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016

Recommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division

File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division

Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33

RESULTS AND DISCUSSION

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA

3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore.

Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

BRIC DIABETES DRUGS MARKET

Global Aspergillosis Drugs Market Professional Survey Report 2016

PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA

Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines

TRADE MARKS REGISTRY AHMEDABAD

TRADE MARKS REGISTRY AHMEDABAD

Companies Database, Mobile Database, Id Database, Credit

10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE

Recommendation:- The 19 th SEC - (Oncology & Hematology) deliberated the proposals on and recommended the following:-

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES

New Delhi, the 18 th December, 2017 ORDER

PDF of Trial CTRI Website URL -

Recent trends and challenges

Exporting Heart Disease to Developing Countries: India. Zeeshan Ali, Ph.D.

A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database

Ameya works predominantly in the architectural design, interiors and project management segments in healthcare industry

List of Ordinary Members as on NAME OF THE COMPANY 1 AADIVIGHNESH CHEM PVT LTD 2 AANJANEYA LIFECARE LTD 3 AARTI DRUGS LTD 4 ACCENT

ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet

PDF of Trial CTRI Website URL -

Subsequent New Drugs Division. M/s.Troikaa. M/s. Olive Healthcare. Biological Division. M/s. Wockhardt Ltd. Global Clinical Trial Division

AGENDA PAPERS FOR THE EIGHTEENTH MEETING SUB-COMMITTEE ON LARGE ANIMALS (SCLA)

Global Coverage. Regional Coverage. Company Coverage. Country Coverage. Global Coverage Regional Coverage Country Coverage

REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38

Education. Current Activities

Case 2:09-cv DMC-CCC Document 1 Filed 03/20/2009 Page 1 of 95. Of Counsel:

CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...

### About Bharat Biotech

Solvay in India January, 2014

Medicines availability short-term supply issues Last updated 01/05/18

Influenza Vaccination Market Research Report Global Forecast till 2023

The Crisis in. Vaccine Development

TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.

New study: Tuberculosis vaccine treatment market research forecast to 20...

It s flu season Sanofi Pasteur intensifies its fight to prevent influenza!

Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 30/04/2016 to 20/12/2016

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)

SEAT MATRIX - FELLOWSHIP PROGRAMMES - CENTRALIZED COUNSELING ADMISSION SESSION. Andhra Pradesh. Andhra Pradesh. Andhra Pradesh.

PDF of Trial CTRI Website URL -

WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract Research Organization

PDF of Trial CTRI Website URL -

Annexure. Reason for failure with Report No. (in Form-13)& Date Misbranded Report No / Dated

INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION ROUND-2

Vascular Endothelial Growth Factor Inhibitor Market

Decisions taken in the 63 rd Meeting of the Genetic Engineering Approval Committee (GEAC) held on 8 th February 2006.

Name of firm/applicant. Torrent Pharmaceuticals. Glenmark Pharmaceuticals. M/s. Torrent Pharmaceutical. Torrent Pharmaceuticals

Hyderabad, India Delegates. A comprehensive Bioanalysis conclave. April 27, Tentative program. Key notes SPONSORSHIP OPPORTUNITIES

Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )

Hyderabad, India Delegates. April 27, Tentative program A comprehensive Bioanalysis conclave. Key notes.

TABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF

PDF of Trial CTRI Website URL -

Subject: Consolidated list of all cases of price fixation of new drugs received from various companies under para 5 of DPCO 2013

What s New

Recommendations: Agend a no. Recommendations. Institute. New Drugs Division /12-DC ArbekacinSulphate Injection 200mg/4ml

PDF of Trial CTRI Website URL -


REF/2012/01/ CTRI Website URL -

Central Inspection Plan Using Risk Based Approach Of Vaccine Manufacturing Units for 2017

Edmund Healthcare Pvt. Ltd.

REF/2014/04/ CTRI Website URL -

Information for Vermont Prescribers of Prescription Drugs

Organ Transplantation Market Research Report- Global Forecast Till 2023

Form IV-A Short-term Inter-State Transactions of Electricity by Trading Licensees ( RTC*)

Information for Vermont Prescribers of Prescription Drugs

MR. VIJAYKUMAR SURYAKANT SHINDE

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL -

Lamivudine Tablets 150 mg (Macleods Pharmaceuticals Ltd), HA424. WHOPAR Part 5 05/2011, version 1.0 LABELLING. Page 1 of 8

PDF of Trial CTRI Website URL -

M/s. Hetero Labs Ltd.

SAMPLE. Asia-Pacific Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central Venous

Information for Vermont Prescribers of Prescription Drugs. Lunesta (eszopiclone tablets)

Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023

ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin Clopidogrel Tablet

FROST & SULLIVAN. Publications Division - Terms and Conditions of Business

Transcription:

S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC 4. M/S. CADILA HEALTHCARE - CT-NOC LIMITED 5. M/S INTAS PHARMACEUTICALS - QUERY LIMITED 6. M/S. BDR LIFESCIENCES - PHARMACEUTICALS PVT LTD 7. M/S AJANTA PHARMA LTD - QUERY (2) MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. TELEFLEX MEDICAL PVT. LTD. 30773 2. M/S. TELEFLEX MEDICAL PVT. LTD. 30772 3. M/S. FAITH BIOTECH PVT. LTD. 30883 SEC 4. M/S. VARDHAMAN REMEDIES PVT. LTD. 33789 SEC 5. M/S. KENTRON BIOTECHNOLOGY PVT. LTD. 31534 SEC 6. M/S. EMERGO INDIA CONSULTING PVT. LTD. 30845 SEC VACCINE DIVISION S. NO. COMPANY NAME DY. NO STATUS 1 M/SGSK ASIA PVT, LTD CLARIFICATION 2 M/S SANOFI PASTEUR INDIA PVT, LTD 37587, 37583 CLARIFICATION & CDL

3 M/S ALCON LABORATORIES INDIA PVT, LTD 26953 APPROVAL 4 M/S SYNAPSE LABS PVT, LTD 37397 APPROVAL 5 M/S BHARAT BIOTECH INTERNATIONAL LTD CLARIFICATION SUBSEQUENT NEW DRUG S. NO. NAME OF THE FIRM REFERENCE NO. FTS NO. TYPE OF 1. M/S BHARAT SERUMS AND VACCINES LIMITED., 36709 59968 DEFICIENCY GLOBAL CLINICAL TRIAL SR. NO. FILE NO. REFERENCE NO. STATUS 1 M/S. NOVARTIS 36638 TL APPROVAL 2 M/S. ASTRAZENECA 50448/50450 CT NOC& TL APPROVAL S 3 M/S. QUINTILES 37171 CHANGE IN CRO APPROVAL 4 M/S. MAYA CLINICALS 5 M/S. NOVO NORDISK 36663 SITE APPROVAL - MINUTES OF SEC COSMETIC DIVISION S. NO. COMPANY NAME DIARY NO. STATUS 1. M/S. SAKURA EBIZ PRIVATE LIMITED, NEW 32700 APPROVAL

DELHI 2. M/S. S.H.A.M.K. INTERNATIONAL PVT. LTD, MUMBAI 32369 APPROVAL 3. M/S. GEOSMATIC COSMECUTICALS & COSMOCARE PVT. LTD, MAHARASTRA 23034 APPROVAL 4. M/S. LIBERTY PERFUMES, MUMBAI 28881 APPROVAL 5. M/S. RONAK HEALTHCARE PVT. LTD, VADODARA, 390001 25748 APPROVAL 6. M/S. ORIFLAME INDIA PVT. LTD, NEW DELHI 29599 APPROVAL 7. M/S KUNDAN CUTLERY PVT LTD., MUMBAI- 400063 27696 APPROVAL 8. M/S. SHREE HARDEV ENTERPRISES, MUMBAI- 400705 28945 APPROVAL 9. M/S. L'OREAL INDIA PVT. LTD, LOWER PAREL, MUMBAI 27772, 25373, 25559, 27133, 25583, 25558, 27132, 29178, 29843, 31948, APPROVAL

31313 10. M/S. MARKS AND SPENCER RELIANCE INDIA PVT LTD., MUMBAI-400002 28432, 30787, 32659, 32537 APPROVAL IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. DOLPHIN INTERNATIONAL. 39483,39482 CLARIFICATION 2. SUN PHARMACEUTICAL INDUSTRIES LTD. 39543,39544 CLARIFICATION REGISTRATION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. CENTAUR CHEM. 30875 APPROVAL 2. KIMIA BIOSCIENCES PVT. LTD. 31841 APPROVAL 3. NOVARTIS HEALTHCARE PVT. LTD. 21734 APPROVAL 4. UNI-CHEMIE INTERNATIONAL, 30803 APPROVAL 5. GANGWAL CHEMICALS PVT. LTD. 29970 APPROVAL 6. SHAH TC 24604 APPROVAL 7. CHEMO AG, 30123 CLARIFICATION 8. THE MANISH GLOBAL 22758 CLARIFICATION 9. DIVINNE SBR INTERNATIONAL 32632 CLARIFICATION PVT.LTD. 10. SANOFI SYNTHELABO PVT.LTD. 27692 AMENDMENT 11. EASTERN CHEMICAL PVT.LTD. 16233 AMENDMENT 12. MAN MILL CHEMICALS PVT.LTD. 34866 AMENDMENT RULE-37/MISC./SHELF LIFE S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. MERCK LTD. 34951 CLARIFICATION BE NOC FOR EXPORT

S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT. LTD., NAVI MUMBAI-400 709 2. M/S. AIZANT DRUG RESEARCH SOLUTIONS PVT. LTD., HYDERABAD-500 014 3. M/S. AIZANT DRUG RESEARCH SOLUTIONS PVT. LTD., HYDERABAD-500 014 4. M/S. ANACIPHER CLINICAL RESEARCH ORGANISATION (A DIVISION OF INDOCO REMEDIES LTD.), HYDERABAD-500 013 5. M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA LTD., HYDERABAD-500 090 6. M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA LTD., HYDERABAD-500 090 7. M/S. AZIDUS LABORATORIES LTD., CHENNAI-600 048 8. M/S. AZIDUS LABORATORIES LTD., CHENNAI-600 048 9. M/S. CLIANTHA RESEARCH LIMITED, 36698 APPROVAL 36995 CLARIFICATION 36994 CLARIFICATION 36486 CLARIFICATION 36835 CLARIFICATION 36836 CLARIFICATION 36573 CLARIFICATION 37086 APPROVAL 37206 AMENDMENT

AHMEDABAD-380 054 10. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD-380 054 11. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD-380 054 12. M/S. DR. REDDY S LABORATORIES LTD., HYDERABAD-500 034 13. M/S. DR. REDDY S LABORATORIES LTD., HYDERABAD-500 034 14. M/S. EMCURE PHARMACEUTICALS LTD., PUNE-411 026 15. M/S. GLENMARK PHARMACEUTICALS LTD., NAVI MUMBAI- 400 705 16. M/S. INVENTIA HEALTHCARE PVT. LTD., THANE (WEST)- 400 604 17. M/S. LAMBDA THERAPEUTIC RESEARCH LTD., AHMEDABAD-380 061 18. M/S. LOTUS LABS PVT. LTD., BANGALORE-560 034 19. M/S. LOTUS LABS PVT. LTD., BANGALORE-560 034 20. M/S. LUPIN LIMITED 36981 APPROVAL 37084 APPROVAL 32077 CLARIFICATION 37225 APPROVAL 37354 CLARIFICATION 36921 CLARIFICATION 36886 CLARIFICATION 37210 CLARIFICATION 37220 APPROVAL 36779 APPROVAL 36929 CLARIFICATION

21. M/S. LUPIN LIMITED 22. M/S. LUPIN LIMITED 23. M/S. LUPIN LIMITED 24. M/S. LUPIN LIMITED 25. M/S. LUPIN LIMITED 26. M/S. MACLEODS PHARMACEUTICALS LTD., ANDHERI (EAST), MUMBAI-400 059 27. M/S. MANIPAL ACUNOVA LIMITED, MANIPAL -576104 28. M/S. MSN LABORATORIES PVT. LTD., MEDAK-502 307 29. M/S. RA CHEM PHARMA LTD., BALANAGAR, HYDERABAD-500 037 30. M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA-390 020 31. M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA-390 020 37256 APPROVAL 37258 APPROVAL 37085 APPROVAL 37468 APPROVAL 37469 APPROVAL 37387 APPROVAL 37430 APPROVAL 37088 APPROVAL 37280 APPROVAL 37328 CLARIFICATION 37037 CLARIFICATION

32. M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA-390 020 33. M/S. VEEDA CLINICAL RESEARCH PVT. LTD., AHMEDABAD-380 015 34. M/S. VEEDA CLINICAL RESEARCH PVT. LTD., AHMEDABAD-380 015 35. M/S. VERGO CLINICALS, GOA-403 110 36. M/S. WATSON PHARMA PVT. LTD., NAVI MUMBAI-400614 37. M/S. WATSON PHARMA PVT. LTD., NAVI MUMBAI-400614 37509 APPROVAL 37004 CLARIFICATION 36993 APPROVAL 36368 CLARIFICATION 37226 ADDITIONAL STUDY CENTRE 37223 APPROVAL